Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerBiomarkers to Target Heterogeneous Breast Cancer Stem CellsMorphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: An oncogenic angiogenesis assayGlobal gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancerCharacteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.Circulating tumor cells: from bench to bedsideInteractions with fibroblasts are distinct in Basal-like and luminal breast cancers.Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.Anti-human embryonic stem cell monoclonal antibody Hesca-2 binds to a glycan epitope commonly found on carcinomasGene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma.Tumor intrinsic subtype is reflected in cancer-adjacent tissue.Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug TherapeuticsThe interconnectedness of cancer cell signaling.Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture SystemAldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.The War on Cancer rages on.Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasisBiomarkers for breast cancer stem cells: the challenges ahead.Emerging targeted agents in metastatic breast cancer.Cancer stem cells and their implication in breast cancer.The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance.Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery.Progress towards understanding heterotypic interactions in multi-culture models of breast cancer.Breast cancer stem cell: the roles and therapeutic implications.Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression.Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.Superficial scrapings from breast tumors is a source for biobanking and research purposes.
P2860
Q24628746-1ED1A91D-9D1D-400E-8C1C-BF3E9FE8CC62Q33811149-2235E4A4-EB1E-4A7B-B72F-7A019EB0318FQ33866188-0C4BE5EE-972A-48D6-9D8F-FD359E3CC5A1Q34123869-3846C4BA-CB19-4012-90A2-E2D1582EF111Q34124530-1C5718D3-68B9-49F3-9E9A-480CDA3BFF56Q34307782-9B82657F-1BC1-455B-A169-BC053270EA88Q34610562-6C6726F7-9FAF-4516-9F80-7EE7E2020D16Q34874835-726E384A-9425-4EB8-BDAE-53AEB208EC96Q35084082-49B3966C-1080-4B3D-8ED6-A13F3E11DEB3Q35616195-EDC34284-E507-4506-ACBD-6F747718DE9CQ35624103-C11D2766-9AD2-4A31-B06E-5DAEB8246E45Q35626527-298DC2A7-448B-4447-B17D-EBB6CCB1393CQ35669733-B7012852-A23A-45A7-A79A-18D75E69B1C9Q35781757-4D5CEB0D-2475-4443-B9B5-6D298A435489Q36184940-4947FBAD-8A21-42B0-BC12-8BCAD7111BD5Q36806793-DF764594-8043-44C8-9E90-CE04B5A7EF0DQ37478602-C85BEF3D-D50B-498B-ABD1-ED1E77F72EBEQ37513954-7A4379DE-2E4A-45AC-9591-2C86483B1E19Q37691895-7161C0BB-53FA-4708-8E93-61B100BF2F1FQ37946408-B200C503-00A5-4E3A-BBAB-3CB1BCDF7255Q38086421-793CFBBA-1BFD-4590-B9B1-5D09237DF91AQ38207159-358C3DD2-7682-4149-9BCA-4F997164B8ADQ38216639-3DEC898D-611A-49E1-9B43-F8CAD03BBCB1Q38383345-2AF57648-BE32-4ECA-AC53-12F16D225C1FQ38813025-46DFD019-0DFE-41A6-83B0-4EFAC6EEBA60Q38929036-4101DCF9-B03F-43D8-A1A1-B3CD5A542BAEQ39208225-7B17D5E5-3849-4584-B8B3-3C4A6B914E26Q42513994-B1217C61-7CBC-4C75-8FD0-72744AD18773Q53090729-1AB691AD-7D44-4264-B09D-99575B3110FC
P2860
Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Tumor-endothelial interaction ...... s in early-stage breast cancer
@ast
Tumor-endothelial interaction ...... s in early-stage breast cancer
@en
Tumor-endothelial interaction ...... s in early-stage breast cancer
@nl
type
label
Tumor-endothelial interaction ...... s in early-stage breast cancer
@ast
Tumor-endothelial interaction ...... s in early-stage breast cancer
@en
Tumor-endothelial interaction ...... s in early-stage breast cancer
@nl
prefLabel
Tumor-endothelial interaction ...... s in early-stage breast cancer
@ast
Tumor-endothelial interaction ...... s in early-stage breast cancer
@en
Tumor-endothelial interaction ...... s in early-stage breast cancer
@nl
P2093
P2860
P356
P1433
P1476
Tumor-endothelial interaction ...... s in early-stage breast cancer
@en
P2093
Brigitte M L Vogel-Durrer
Christoph Rochlitz
Martin Buess
Michal Rajski
Richard Herrmann
P2860
P304
P356
10.1593/NEO.09670
P407
P577
2009-10-01T00:00:00Z